Macquarie Group LTD Trans Medics Group, Inc. Transaction History

Macquarie Group LTD

$79.1 Billion
Q2 2025

A detailed history of Macquarie Group LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 952,105 shares of TMDX stock, worth $110 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

952,105

Previous 1,115,596 14.66%

Holding current value

$110 Million

Previous $75.1 Million 69.99%

% of portfolio

0.16%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$67.67 - $143.04 $11.1 Million - $23.4 Million	-163,491 Reduced 14.66%	952,105 $128 Million
Q1 2025 May 15, 2025	BUY	$56.73 - $79.42 $6.98 Million - $9.78 Million	123,096 Added 12.4%	1,115,596 $75.1 Million
Q4 2024 Feb 14, 2025	BUY	$59.28 - $144.9 $5.71 Million - $14 Million	96,389 Added 10.76%	992,500 $61.9 Million
Q3 2024 Nov 14, 2024	SELL	$135.68 - $176.11 $8.17 Million - $10.6 Million	-60,188 Reduced 6.29%	896,111 $141 Million
Q2 2024 Aug 09, 2024	SELL	$72.62 - $150.62 $24.8 Million - $51.4 Million	-341,420 Reduced 26.31%	956,299 $144 Million
Q1 2024 May 14, 2024	SELL	$70.86 - $89.93 $16.2 Million - $20.5 Million	-228,100 Reduced 14.95%	1,297,719 $96 Million
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $6.8 Million - $15 Million	-185,032 Reduced 10.82%	1,525,819 $120 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $892,146 - $1.6 Million	16,685 Added 0.98%	1,710,851 $93.7 Million
Q2 2023 Aug 14, 2023	SELL	$66.23 - $88.73 $3.39 Million - $4.54 Million	-51,191 Reduced 2.93%	1,694,166 $142 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $10.8 Million - $16.6 Million	-202,115 Reduced 10.38%	1,745,357 $132 Million
Q4 2022 Feb 21, 2023	BUY	$39.08 - $64.29 $7.71 Million - $12.7 Million	197,273 Added 11.27%	1,947,472 $120 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $2.36 Million - $4.16 Million	-74,636 Reduced 4.09%	1,750,199 $73.1 Million
Q2 2022 Aug 15, 2022	SELL	$20.56 - $32.15 $5.18 Million - $8.1 Million	-251,901 Reduced 12.13%	1,824,835 $57.4 Million
Q1 2022 May 16, 2022	BUY	$12.58 - $26.94 $5.35 Million - $11.5 Million	425,450 Added 25.76%	2,076,736 $55.9 Million
Q4 2021 Feb 11, 2022	BUY	$19.16 - $32.68 $518,661 - $884,647	27,070 Added 1.67%	1,651,286 $31.6 Million
Q3 2021 Nov 12, 2021	BUY	$25.92 - $34.51 $2.72 Million - $3.63 Million	105,095 Added 6.92%	1,624,216 $53.7 Million
Q2 2021 Aug 13, 2021	BUY	$21.63 - $40.07 $11.9 Million - $22.1 Million	550,627 Added 56.85%	1,519,121 $50.4 Million
Q1 2021 May 14, 2021	BUY	$17.75 - $47.82 $131,722 - $354,872	7,421 Added 0.77%	968,494 $40.2 Million
Q4 2020 Feb 16, 2021	BUY	$11.91 - $19.9 $2.58 Million - $4.3 Million	216,212 Added 29.03%	961,073 $19.1 Million
Q3 2020 Nov 13, 2020	BUY	$13.78 - $18.84 $4.98 Million - $6.8 Million	361,110 Added 94.1%	744,861 $10.3 Million
Q2 2020 Aug 11, 2020	BUY	$11.66 - $18.26 $4.47 Million - $7.01 Million	383,751 New	383,751 $6.88 Million

Others Institutions Holding TMDX

# of Institutions

415

Shares Held

29.8M

Call Options Held

1.19M

Put Options Held

777K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.68B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Trans Medics Group, Inc. Transaction History